Seizure suppression by gain-of-function escargot mutations.
about
Drosophila sodium channel mutations: Contributions to seizure-susceptibilityCalcium Imaging of Neuronal Activity in Drosophila Can Identify Anticonvulsive CompoundsLithium-Responsive Seizure-Like Hyperexcitability Is Caused by a Mutation in the Drosophila Voltage-Gated Sodium Channel Gene paralytic.A Drosophila systems model of pentylenetetrazole induced locomotor plasticity responsive to antiepileptic drugs.Increased persistent Na+ current contributes to seizure in the slamdance bang-sensitive Drosophila mutant.Structural mass spectrometry analysis of lipid changes in a Drosophila epilepsy model brain.Transcription Factor Antagonism Controls Enteroendocrine Cell Specification from Intestinal Stem Cells.Structural and functional evaluation of C. elegans filamins FLN-1 and FLN-2.The mei-P26 gene encodes a RING finger B-box coiled-coil-NHL protein that regulates seizure susceptibility in Drosophilia.Therapeutic modulation of eIF2α phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models.From bench to drug: human seizure modeling using DrosophilaSeizure and epilepsy: studies of seizure disorders in Drosophila.Seizure suppression through manipulating splicing of a voltage-gated sodium channelDNA topoisomerase I inhibitors ameliorate seizure-like behaviors and paralysis in a Drosophila model of epilepsy.Phospholipid Homeostasis Regulates Dendrite Morphogenesis in Drosophila Sensory Neurons.TDP-43 Promotes Neurodegeneration by Impairing Chromatin Remodeling.Reduced Neuronal Transcription of Escargot, the Drosophila Gene Encoding a Snail-Type Transcription Factor, Promotes Longevity.
P2860
Q28082964-CE949931-1971-4DBF-BA48-BC3FD54C9B85Q28550075-60556E47-C7F6-4097-B01F-0691ECD1CFB0Q30370008-7EB930C5-F5FE-4F23-8741-BD153F1297A8Q30486566-FFD6D4EC-25C5-41FC-A3ED-B48604E803CDQ30502114-33C857A2-C74D-4F21-B7A5-57DAC221563AQ33551222-19CA1BEF-16B5-4D71-8B38-509ED8B7FBF1Q33681403-95152875-CB03-44E0-A4F5-6B50C0698949Q33974916-4726ED85-469F-4A08-BD7D-61B2E1839E7EQ34573468-4251315D-C79C-41A8-9264-8DD00EF84E9BQ35066495-9D672FCD-681D-4737-83AE-B2084BA2B025Q36496588-CCD770F4-9AA5-41C4-80DF-F2893087B032Q37929935-1D68CEC1-1F8F-4BB0-9C73-CB670C3B80AFQ41033198-4AF0C508-461D-48F5-9435-F57C4219D799Q43213000-B77B2AE0-2CAF-4164-83C5-45DF536986C9Q44084551-79F2C7EA-326A-4CA7-A725-D3F3645367D6Q47387588-ADC80F7F-358D-4F7F-B82D-7A4D9CC109FFQ55260737-69007B67-34B5-40B9-8062-687FB99F82E5
P2860
Seizure suppression by gain-of-function escargot mutations.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Seizure suppression by gain-of-function escargot mutations.
@ast
Seizure suppression by gain-of-function escargot mutations.
@en
Seizure suppression by gain-of-function escargot mutations.
@nl
type
label
Seizure suppression by gain-of-function escargot mutations.
@ast
Seizure suppression by gain-of-function escargot mutations.
@en
Seizure suppression by gain-of-function escargot mutations.
@nl
prefLabel
Seizure suppression by gain-of-function escargot mutations.
@ast
Seizure suppression by gain-of-function escargot mutations.
@en
Seizure suppression by gain-of-function escargot mutations.
@nl
P2093
P2860
P1433
P1476
Seizure suppression by gain-of-function escargot mutations.
@en
P2093
Daria S Hekmat-Scafe
Kim N Dang
Mark A Tanouye
P2860
P304
P356
10.1534/GENETICS.104.036558
P407
P577
2005-01-16T00:00:00Z